Home »
Academic Articles »
C »
Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening
Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening
Shihua Dong
(Research and Development Department Shanghai Epiprobe Bio‐Technology Co., Ltd Shanghai China)
Qi Lu
(Department of Obstetrics and Gynecology Jinshan Hospital of Fudan University Shanghai China)
Peng Xu
(Shanghai Public Health Clinical Center Department of General Surgery, Huashan Hospital Cancer Metastasis Institute Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences Shanghai Medical College, Fudan University Shanghai China)
Limei Chen
(Medical Center for Diagnosis and Treatment of Cervical Disease, Obstetrics and Gynecology Hospital, Fudan University Shanghai Key Laboratory of Female Reproductive Endocrine‐Related Diseases Shanghai China)
Xiaoling Duan
(Department of Obstetrics and Gynecology Jinshan Hospital of Fudan University Shanghai China)
Zhanrui Mao
(Research and Development Department Shanghai Epiprobe Bio‐Technology Co., Ltd Shanghai China)
Baolong Zhang
(Shanghai Public Health Clinical Center Department of General Surgery, Huashan Hospital Cancer Metastasis Institute Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences Shanghai Medical College, Fudan University Shanghai China)
Long Sui
(Medical Center for Diagnosis and Treatment of Cervical Disease, Obstetrics and Gynecology Hospital, Fudan University Shanghai Key Laboratory of Female Reproductive Endocrine‐Related Diseases Shanghai China)
Yudong Wang
(Department of Gynecology, International Peace Maternity and Child Health Hospital Shanghai Jiaotong University School of Medicine Shanghai China)
Wenqiang Yu
(Shanghai Public Health Clinical Center Department of General Surgery, Huashan Hospital Cancer Metastasis Institute Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences Shanghai Medical College, Fudan University Shanghai China)
Journal: Clinical and Translational Medicine
•
• Wiley
• ISSN: 2001-1326
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Shihua Dong, Qi Lu, Peng Xu, et al. (2021). "Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening". Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.457